Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
944.4500 0.30 (0.03%)
NSE Nov 14, 2025 15:47 PM
Volume: 592.7K
 

logo
Zydus Lifesciences Ltd.
21 Nov 2019
944.45
0.03%
Business Line
Cadila Healthcare said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest p
Zydus Lifesciences L.. has an average target of 1033.33 from 6 brokers.
USFDA approves Zydus Cadila's Dinitrate tablets, Desonide Cream
Business Line | 21 Nov 2019 1 more
More from Zydus Lifesciences Ltd.
Recommended
Market trades lower, MRF's Q2 net profit grows 12% YoY
Trendlyne Marketwatch | 14 Nov 2025, 03:30PM
Global indices climb toward record highs, but valuations flash warning signs
The Baseline | 13 Nov 2025, 02:55PM
Earnings Call Transcript - Cadila Healthcare
| 14 Feb 2020, 01:51PM